Skip to content Home / Companies / INCY INC
INCYTE CORP (INCY) S&P 500 XNAS SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH Net insider selling (90d)
Latest INCY Insider Trades Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.
Headquarters WILMINGTON, DE
Employees 2,844
Listed 1993
Exchange XNAS https://www.incyte.com SEC filings for INCY on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 21 132,139 $15.67M Grant or award 50 742,620 Option exercise 36 101,226
INCY Insider Transactions (Form 4) 63 133 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 3.
Recent INCY Form 8-K Filings 5
Recent INCY Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 19, 2026 PABLO CAGNONI Officer 10,801 $1.36M View on EDGAR Aug 12, 2026 PABLO CAGNONI Officer
INCY Insider Trading - FAQ
What is the latest insider trade for INCY? INCYTE CORP (INCY) had 39 insider filings in the last 90 days, with the most recent on 2026-08-27. The full record for INCY runs to 133 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying INCY stock? No insider purchases of INCY were filed in the last 90 days.
How many insiders are selling INCY stock? 21 insider sales of INCY were filed in the last 90 days, totaling $15.67M.
Where can I see INCY SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks INCY Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow INCY insider buys? Create a free InsiderAlpha account and press Watch on this page to add INCY to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track INCY insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $25.21B
P/E ratio -
Dividend yield -
Average volume 1.85M
52 week high $132.60
52 week low $81.09
Today's high $127.74
Today's low $123.08
Open $127.74
Volume 1.22M
Previous close $127.74
Shares outstanding 202.70M Market cap
$25.21B
2,844 employees
INCY Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 21 sales totaling $15.67M.
Most-Active INCY Insiders - Last 90 Days 10 Tax withholding / forfeiture 15 86,431
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jun 8, 2026 EH Edmund Harrigan - Director Grant or award Common Stock 1,642 $0.00 -
Jun 8, 2026 EH Edmund Harrigan - Director Grant or award Non Qualfied Stock Option (right to buy) 6,111 $0.00 -
Jun 8, 2026 PC Paul J. Clancy - Director Grant or award Common Stock 1,642 $0.00 -
Jun 8, 2026 PC Paul J. Clancy - Director Grant or award Non Qualfied Stock Option (right to buy) 6,111 $0.00 -
Jun 8, 2026 JF Jacqualyn A. Fouse - Director Grant or award Non Qualfied Stock Option (right to buy) 6,111 $0.00 -
Jun 8, 2026 JB Jean Jacques Bienaime - Director Grant or award Non Qualfied Stock Option (right to buy) 6,111 $0.00 -
Jun 8, 2026 KH Katherine A. High - Director Grant or award Non Qualfied Stock Option (right to buy) 6,111 $0.00 -
Jun 8, 2026 OB Otis W. Brawley - Director Grant or award Non Qualfied Stock Option (right to buy) 6,111 $0.00 -
Jun 8, 2026 OB Otis W. Brawley - Director Grant or award Common Stock 1,642 $0.00 -
Jun 4, 2026 TT Thomas Tray - Officer Open-market sale Common Stock 2,639 $100.00 $264K
Jun 4, 2026 TT Thomas Tray - Officer Option exercise Non-Qualified Stock Option (right to buy) 2,639 $0.00 -
Jun 4, 2026 TT Thomas Tray - Officer Option exercise Common Stock 2,639 $83.83 $221K
Jun 1, 2026 PC Pablo J. Cagnoni - Officer Tax withholding / forfeiture Common Stock 25,469 $95.59 $2.43M
May 26, 2026 TT Thomas Tray - Officer Open-market sale Common Stock 2,051 $97.35 $200K
May 26, 2026 JB Jean Jacques Bienaime - Director Option exercise Non-Qualified Stock Option (right to buy) 15,000 $0.00 -
May 19, 2026 PC Paul J. Clancy - Director Option exercise Common Stock 15,000 $84.53 $1.27M
May 19, 2026 PC Paul J. Clancy - Director Open-market sale Common Stock 15,000 $94.93 $1.42M
May 19, 2026 PC Paul J. Clancy - Director Option exercise Non-Qualified Stock Option (right to buy) 15,000 $0.00 -
May 6, 2026 SS Steven H. Stein - Officer Grant or award Common Stock 44,124 $0.00 -
May 4, 2026 SU Suketu Upadhyay - Officer Grant or award Common Stock 26,343 $0.00 -
May 4, 2026 SU Suketu Upadhyay - Officer Grant or award Employee Stock Option (right to buy) 38,429 $0.00 -
May 4, 2026 SU Suketu Upadhyay - Officer Grant or award Performance Shares 13,171 $0.00 -
Apr 17, 2026 PC Pablo J. Cagnoni - Officer Option exercise Common Stock 6,077 $64.25 $390K
Apr 17, 2026 PC Pablo J. Cagnoni - Officer Option exercise Common Stock 12,590 $71.93 $906K
Apr 17, 2026 PC Pablo J. Cagnoni - Officer Open-market sale Common Stock 18,667 $96.50 $1.80M
Apr 17, 2026 PC Pablo J. Cagnoni - Officer Option exercise Employee Stock Option (right to buy) 6,077 $0.00 -
Apr 17, 2026 PC Pablo J. Cagnoni - Officer Option exercise Employee Stock Option (right to buy) 12,590 $0.00 -
Apr 15, 2026 WM William Meury - Officer Option exercise Common Stock 125,000 $0.00 -
Apr 15, 2026 SS Steven H. Stein - Officer Grant or award Common Stock 39,049 $0.00 -
Mar 31, 2026 EH Edmund Harrigan - Director Grant or award Common Stock 269 $94.12 $25K
Mar 31, 2026 PC Paul J. Clancy - Director Grant or award Common Stock 265 $94.12 $25K
Mar 25, 2026 MT Matteo Trotta - Officer Tax withholding / forfeiture Common Stock 537 $92.23 $50K
Mar 17, 2026 PC Pablo J. Cagnoni - Officer Option exercise Common Stock 7,166 $61.18 $438K
Mar 17, 2026 PC Pablo J. Cagnoni - Officer Option exercise Common Stock 11,501 $64.25 $739K
Mar 17, 2026 PC Pablo J. Cagnoni - Officer Open-market sale Common Stock 18,667 $94.24 $1.76M
Mar 17, 2026 PC Pablo J. Cagnoni - Officer Option exercise Employee Stock Option (right to buy) 7,166 $0.00 -
Mar 17, 2026 PC Pablo J. Cagnoni - Officer Option exercise Employee Stock Option (right to buy) 11,501 $0.00 -
Feb 19, 2026 PC Pablo J. Cagnoni - Officer Option exercise Common Stock 13,093 $61.76 $809K
Feb 19, 2026 PC Pablo J. Cagnoni - Officer Option exercise Common Stock 5,575 $61.18 $341K
Feb 19, 2026 PC Pablo J. Cagnoni - Officer Open-market sale Common Stock 18,668 $100.91 $1.88M
Feb 19, 2026 PC Pablo J. Cagnoni - Officer Option exercise Employee Stock Option (right to buy) 13,093 $0.00 -
Feb 19, 2026 PC Pablo J. Cagnoni - Officer Option exercise Employee Stock Option (right to buy) 5,575 $0.00 -
Feb 2, 2026 LH Lee Heeson - Officer Tax withholding / forfeiture Common Stock 111 $102.67 $11K
Jan 16, 2026 LH Lee Heeson - Officer Grant or award Common Stock 8,911 $0.00 -
Jan 16, 2026 PC Pablo J. Cagnoni - Officer Grant or award Employee Stock Option (right to buy) 28,475 $0.00 -
$NRC
NRC HEALTH
Pablo J. Cagnoni - OfficerOpen-market sale$1.36M
